Coherus Oncology CHRS
NASDAQ CHRS
$0.99 -0.08 (-7.48%)
At close: Oct 16, 2026 · 4:00 PM EDT

Coherus Oncology (CHRS) EV to EBIT (2019 - 2020)

Updated

Coherus Oncology's EV to EBIT was 4.60 in Q4 2020, down 54.5% from 10.10 a year earlier but up 4.0% from the prior quarter.

Analysis

Coherus Oncology (CHRS) EV to EBIT (2019 - 2020) Analysis & Trends

From Q3 2019 onward, Coherus Oncology has reported EV to EBIT for 6 quarters.

  • In earlier years, EV to EBIT was 10.10 in FY2019.
  • Quarterly EV to EBIT has moved between 4.04 (Q2 2020) and 559.93 (Q3 2019) over five years.
  • Per Business Quant data, CHRS's EV to EBIT in the three quarters before Q4 2020 was 4.42 (Q3 2020), 4.04 (Q2 2020) and 5.79 (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Coherus Oncology 155.59 Mn -480.55 Mn 10.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 4.60
Sep 30, 2020 4.42
Jun 30, 2020 4.04
Mar 31, 2020 5.79
Dec 31, 2019 10.10
Sep 30, 2019 559.93
API Access

Coherus Oncology EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=CHRS&period=max&api_key=YOUR_API_KEY